Key Findings:  Based on body mass, non-obese patients undergoing partial nephrectomy had significantly higher levels of anandamide (AEA) N-oleoylethanolamine (OEA), and N-palmitoylethanolamine (PEA). This information could help develop novel therapeutic options that target the endocannabinoid system in preventing renal ischemia.
Type of Study:  Clinical Trial
Study Sample Size:  16
Study Result:  Positive
Study Location(s):  Israel
Year of Pub:  2023
Cannabinoids Studied:  Anandamide (AEA), Endocannabinoid (unspecified), Other Related Compounds, Palmitoylethanolamide (PEA)
Phytocannabinoid Source:  Not Applicable